Last reviewed · How we verify

NCT06392321

Dexmedetomidine vs Fentanyl in Controlling Labor Pain

Completed NA Last updated 30 April 2024
What this trial tests

NA trial testing Fentanyl in Labor Pain in 90 participants. Completed in 31 December 2023.

Timeline
1 April 2023
Primary endpoint
30 November 2023
31 December 2023

Quick facts

Lead sponsorAl-Azhar University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment90
Start date1 April 2023
Primary completion30 November 2023
Estimated completion31 December 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Al-Azhar University

Who can join

Adults 18 to 40, female only, with Labor Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

As most woman experience agonizing pain throughout vaginal labor. Adjuvants were added to intrathecal bupivacaine aiming to improve the quality of analgesia. This study aimed to assess the efficacy and outcome of intrathecal dexmedetomidine and fentanyl in controlling pain during delivery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Fentanyl

Trials testing the same drug.

Other recruiting trials for Labor Pain

Currently open trials in the same condition.

Other Al-Azhar University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06392321.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing